Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Divergent mutational processes distinguish hypoxic and normoxic tumours
PCAWG Consortium
Section of Computational Biology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Siteman Cancer Center
Division of Oncology
DBBS - Cancer Biology
DBBS - Computational and Systems Biology
DBBS - Developmental, Regenerative and Stem Cell Biology
DBBS - Molecular Genetics and Genomics
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Section of Medical Oncology
DBBS - Human and Statistical Genetics
McDonnell Genome Institute (MGI)
Department of Genetics
Institute of Clinical and Translational Sciences (ICTS)
Rheumatic Diseases Research Resource-Based Center
DBBS - Immunology
Section of Stem Cell Biology
Section of Bone Marrow Transplant & Leukemia
Division of Gynecologic Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
90
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Divergent mutational processes distinguish hypoxic and normoxic tumours'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Types
40%
Driver Genes
20%
Driver mutations
20%
Evolutionary Distinctiveness
20%
Evolutionary Landscape
20%
Evolutionary Trajectory
20%
Gene Feature
20%
Gene Level
20%
Genomic Landscape
20%
Hypoxia
100%
Hypoxia Tumor
20%
Hypoxic Tumors
40%
Molecular Oxygen
20%
Mutational Load
20%
Mutational Processes
100%
Mutational Signatures
20%
Non-coding Drivers
20%
Normoxic
100%
Pan-cancer
20%
Pan-cancer Analysis
20%
Primary Tumor
20%
Tumor
100%
Tumor Hypoxia
20%
Tumor Protein p53 (TP53)
20%
Tumor Subtype
20%
Unknown Etiology
20%
Whole Genome
20%
Whole-genome Sequence Data
20%
Biochemistry, Genetics and Molecular Biology
Evolution
100%
Genomics
33%
Mutational Load
33%
Pan-cancer
66%
Tumor Hypoxia
33%
Whole Genome Sequencing
33%